195 related articles for article (PubMed ID: 3914843)
21. Monoclonal IgM rheumatoid factor-like anti-globulins enhance the inhibitory effects of Plasmodium falciparum-specific monoclonal antibodies in vitro.
Stuart MK; Green TJ
Parasitology; 1990 Oct; 101 Pt 2():177-85. PubMed ID: 2263412
[TBL] [Abstract][Full Text] [Related]
22. Plasmodium falciparum antigens synthesized by schizonts and stabilized at the merozoite surface when schizonts mature in the presence of protease inhibitors.
Lyon JA; Haynes JD
J Immunol; 1986 Mar; 136(6):2245-51. PubMed ID: 3512710
[TBL] [Abstract][Full Text] [Related]
23. Pf332-C231-reactive antibodies affect growth and development of intra-erythrocytic Plasmodium falciparum parasites.
Balogun HA; Awah NW; Farouk SE; Berzins K
Vaccine; 2011 Dec; 30(1):21-8. PubMed ID: 22064263
[TBL] [Abstract][Full Text] [Related]
24. A rhoptry antigen of Plasmodium falciparum contains conserved and variable epitopes recognized by inhibitory monoclonal antibodies.
Schofield L; Bushell GR; Cooper JA; Saul AJ; Upcroft JA; Kidson C
Mol Biochem Parasitol; 1986 Feb; 18(2):183-95. PubMed ID: 2421161
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies to a synthetic peptide corresponding to a repeated sequence in the Plasmodium falciparum antigen Pf155.
Ruangjirachuporn W; Wåhlin B; Perlmann H; Carlsson J; Berzins K; Wahlgren M; Udomsangpetch R; Wigzell H; Perlmann P
Mol Biochem Parasitol; 1988 May; 29(1):19-28. PubMed ID: 2455227
[TBL] [Abstract][Full Text] [Related]
26. Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum.
McBride JS; Newbold CI; Anand R
J Exp Med; 1985 Jan; 161(1):160-80. PubMed ID: 2578540
[TBL] [Abstract][Full Text] [Related]
27. PfRON3 is an erythrocyte-binding protein and a potential blood-stage vaccine candidate antigen.
Zhao X; Chang Z; Tu Z; Yu S; Wei X; Zhou J; Lu H; Jiang N; Chen Q
Malar J; 2014 Dec; 13():490. PubMed ID: 25495792
[TBL] [Abstract][Full Text] [Related]
28. Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex.
McBride JS; Heidrich HG
Mol Biochem Parasitol; 1987 Feb; 23(1):71-84. PubMed ID: 2437453
[TBL] [Abstract][Full Text] [Related]
29. Ultrastructural localization of the 150/130 Kd antigens in sexual and asexual blood stages of Plasmodium falciparum-infected human erythrocytes.
Uni S; Masuda A; Stewart MJ; Igarashi I; Nussenzweig R; Aikawa M
Am J Trop Med Hyg; 1987 May; 36(3):481-8. PubMed ID: 3555137
[TBL] [Abstract][Full Text] [Related]
30. Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum.
Dutta S; Haynes JD; Barbosa A; Ware LA; Snavely JD; Moch JK; Thomas AW; Lanar DE
Infect Immun; 2005 Apr; 73(4):2116-22. PubMed ID: 15784553
[TBL] [Abstract][Full Text] [Related]
31. Plasmodium falciparum: differential parasite growth inhibition mediated by antibodies to the antigens Pf332 and Pf155/RESA.
Ahlborg N; Iqbal J; Björk L; Ståhl S; Perlmann P; Berzins K
Exp Parasitol; 1996 Mar; 82(2):155-63. PubMed ID: 8617342
[TBL] [Abstract][Full Text] [Related]
32. Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen.
Dreyer AM; Matile H; Papastogiannidis P; Kamber J; Favuzza P; Voss TS; Wittlin S; Pluschke G
J Immunol; 2012 Jun; 188(12):6225-37. PubMed ID: 22593616
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of monoclonal antibody against Plasmodium falciparum merozoite surface antigen 2.
Khosravi A; Asadollahy E; Ghafourian S; Sadeghifard N; Mohebi R
Asian Pac J Trop Med; 2013 Oct; 6(10):798-803. PubMed ID: 23870469
[TBL] [Abstract][Full Text] [Related]
34. Antigenic diversity and size diversity of P. falciparum antigens in isolates from Gambian patients. II. the schizont surface glycoprotein of molecular weight approximately 200 000.
Howard RJ; McBride JS; Aley SB; Marsh K
Parasite Immunol; 1986 Jan; 8(1):57-68. PubMed ID: 2421226
[TBL] [Abstract][Full Text] [Related]
35. Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA.
Favuzza P; Blaser S; Dreyer AM; Riccio G; Tamborrini M; Thoma R; Matile H; Pluschke G
Malar J; 2016 Mar; 15():161. PubMed ID: 26979066
[TBL] [Abstract][Full Text] [Related]
36. Cross-reactivity of antibody against an epitope of the Plasmodium falciparum second merozoite surface antigen.
Saul A; Lord R; Jones G; Geysen HM; Gale J; Mollard R
Parasite Immunol; 1989 Nov; 11(6):593-601. PubMed ID: 2482473
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies to Plasmodium falciparum and their characterization.
Rajyalakshmi M; Kumar R
Hybridoma; 1995 Feb; 14(1):59-66. PubMed ID: 7768533
[TBL] [Abstract][Full Text] [Related]
38. Antibodies reactive with the N-terminal domain of Plasmodium falciparum serine repeat antigen inhibit cell proliferation by agglutinating merozoites and schizonts.
Pang XL; Mitamura T; Horii T
Infect Immun; 1999 Apr; 67(4):1821-7. PubMed ID: 10085023
[TBL] [Abstract][Full Text] [Related]
39. Characterization of monoclonal antibodies directed against erythrocytic stage antigens of Plasmodium berghei.
Wiser MF
Eur J Cell Biol; 1986 Oct; 42(1):45-51. PubMed ID: 3539609
[TBL] [Abstract][Full Text] [Related]
40. Anti-MSP11 IgG inhibits Plasmodium falciparum merozoite invasion into erythrocytes in vitro.
Tohmoto T; Takashima E; Takeo S; Morita M; Nagaoka H; Udomsangpetch R; Sattabongkot J; Ishino T; Torii M; Tsuboi T
Parasitol Int; 2019 Apr; 69():25-29. PubMed ID: 30385417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
